FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to a hemostatic agent containing hyaluronic acid, characterized by that it additionally contains autoplasma and indigo carmine in the following proportions, wt%: autoplasma 30.0–49.5; hyaluronic acid 30.0–49.5; indigo carmine 1.0–40.0.
EFFECT: invention provides a shorter time for achieving hemostasis and higher hemostatic effect due to injection, reduced risk of hemorrhages in the postoperative period due to content of blood proteins in autoplasma, which perform detoxification, transport function, provide the humoral effect, contain plasma coagulation factors.
1 cl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ENDOSCOPIC STOP OF GASTROINTESTINAL BLEEDING | 2016 |
|
RU2632771C1 |
METHOD OF ENDOSCOPIC HEMOSTASIS IN ULCER GASTRODUODENAL HEMORRHAGES | 2017 |
|
RU2675996C1 |
METHOD FOR TREATMENT OF TEAR-HEMORRHAGIC SYNDROME (MALLORY-WEISS ESOPHAGEAL TEAR) | 2016 |
|
RU2633925C2 |
METHOD FOR ENDOSCOPIC TREATMENT OF ULCEROUS GASTRODUODENAL BLEEDING | 2015 |
|
RU2633588C2 |
METHOD FOR ENDOSCOPIC HEMOSTASIS OF BLEEDING GASTRODUODENAL ULCER | 2021 |
|
RU2762120C1 |
METHOD FOR ENDOSCOPIC HEMOSTASIS IN GASTRIC-DUODENAL HEMORRHAGES | 2011 |
|
RU2498800C2 |
METHOD FOR ENDOSCOPIC TREATMENT OF GASTRODUODENAL ULCERS | 2016 |
|
RU2644934C1 |
METHOD TO STOP GASTRODUODENAL BLEEDING | 2015 |
|
RU2618406C1 |
METHOD OF LASER ENDOSCOPIC HEMOSTASIS | 2017 |
|
RU2684752C2 |
METHOD OF STOPPING ULCER GASTRODUODENAL HEMORRHAGES | 2010 |
|
RU2446753C2 |
Authors
Dates
2019-12-23—Published
2019-09-30—Filed